Investigation of the relationship of latent tuberculosis infection with the development of myeloid and lymphoblastic leukemia
Annotation. The relationship between tuberculosis infection and hemoblastosis has attracted the attention of physicians and has been the basis for a wide variety of assumptions. In the second half of the XIX century, there was expressed an opinion about the unique nature of these pathologies. They explained this phenomenon as the immunochemical affinity of specific tumor and mycobacterial antigens, but not as a result of the persistence of mycobacterium tuberculosis (MBT). The aim of the study was to investigate the association of latent tuberculosis infection and oncogenesis, in particular with leukemias. From transplantable human myeloblasts with acute myeloid leukemia (Kasumi-1) and T-lymphocytes with T-lymphoblastic leukemia (Jurkat), including 0.22 μm filtrate of their lysates were isolated from mycobacterium tuberculosis (MBT) with deficient cell wall (CWD). During primary microscopy, the MBT was found mainly in the form of coccoid. The isolated coccoid Kasumi and Jurkat had close antigen affinity and shared antigens with typical MBT. After prolonged incubation with the growth promoter, not only CWD MBT was isolated from all lysates and filtrates, but isolates with identical morphology and antigenic composition were obtained. This strongly suggested that the MBT and their modified forms could be associated with various types of leukemia. Moreover, the affinity of FLK-BLV isolates with blood of people with latent tuberculosis infection, cattle tuberculosis, CWD forms M. bovis and M. tuberculosis was determined, confirming the role of tuberculosis infection in the development of various forms of the disease depending on the host genome, as well as the features of the adaptive reactions of the infectious agent. In particular, after destruction by ultrasound and filtration through Amicon Ultracel® 100 K and Millex® GP 0.22 μm, their filtrates gave an increase in the number of CWD MBT with acid-resistant elements and had the same antigenic composition, including the original isolates. The long-term incubation of the test material in the growth promoter and numerous transplants on the adapted MyCel DW medium played a major role in the allocation of CWD.
2. Almenoff, P. L., Johnson, A., Lesser, M., & Mattman, L. H. (1996). Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax, 51, 530–533. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8711683.
3. Axelsen, N., Kroll, J., & Weeke, B. A. (Ed.). (1977). A mannual of quantitative immunoelectro-phoresis. Oslo: Universitetsforlaget.
4. Beran, V., Havelkova, M., Kaustova, L., Dvorska, J. & Pavlik, I. (2006). Cell wall deficient forms of mycobacteria: a review. Veterinarni Medicina, 51 (7), 365–389. Retrieved from http://agris.fao.org/agris-search/search.do?recordID=CZ2006000623.
5. Broxmeyer, L. (2017). Cancer and the Science of Denial. Journal of Tumor Medicine and Prevention, 1 (3), 555–563. DOI:10.5281/zenodo.887355.
6. Diller, I. (1970). Experiments with mammalian tumor isolates. Ann. NY Acad. Sci., 174, 655–674.
7. Garnier, Th., Eiglmeier, K., Camus, J-Ch., N. Medina, Mansoor, H., Pryor, M., … Hewinson, R. G. (2003). The complete genome se-quence of Mycobacterium bovis. Proc. Natl. Acad. Sci. USA, 100 (13), 7877–7882. doi: 10.1073/pnas.1130426100.
8. Guliang, H., & Tefu, L. (1999). Mycobacterium tuberculosis L-forms. Microbial Ecology in Health and Disease, 10, 129–133.
9. Livingston, V., & Allen, R. (1948). Presence of consistently recurring invasive mycobacterial forms in tumor cells. Microscop. So.c Bull., 2, 5–18.
10. Lysenko, A., L. Broxmeyer, V., Vlasenko, V. V., Krasochko, P. A., Lemish, A. P. & Krasnikova, E. A. (2016). Further evidence for Cancer as Cell-wall-deficient Mycobacterial Disease. Journal of Molecular Pathological Epidemiology, 1 (1), 1–12. Retrieved from https://molecular-pathological-epidemiology.imedpub.com/further-evidence-for-cancer-as-a-cellwalldeficientmycobacterial-disease.php?aid=17755.
11. Lysenko, A., Vlasenko, V., Broxmeyer, L., Lemish, A. P., Novik, T. P., & Pritychenko, A. N. (2014). The tuberculin skin test: how safe is safe? The tuberculins contain unknown forms capable of reverting to cell-wall deficient mycobacteria. Clin. Exp. Med. Sci., 2, 55–73. http://dx.doi.org/10.12988/cems.2014.445.
12. Lysenko, A. P., Broxmeyer, L., Vlasenko, V. V., Krasochko, P. A., Lemish, A. P., & Krasnikova, E. L. (2017). CWD Tuberculosis Found in Spongiform Disease Formely Attributed to Prions: Its Implication towards Mad Cow Disease, Scrapie and Alzhemer`s. Journal of MPE Molecular Pathological Epidemiology, 3(3), 1–13. Retrieved from https://molecular-pathological-epidemiology.imedpub.com/cwd-tuberculosis-found-in-spongiformdisease-formerly-attributed-to-prions-itsimplication-towards-mad-cow-diseasescrapie-and-alzhei.php?aid=19116.
13. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. (8th ed., v. 1). World Organisation for Animal Health. (2018). ISBN 978-92-95108-18-9.
14. Markova, N., Slavchev, G., & Michailova, L. (2012). Filterable forms and L-forms of Mycobacterium bovis BCG: impact for live vaccine features. Hum. Vaccin Immun-ther., 8 (6), 759–64. doi: 10.4161/hv.19698.
15. Mattman, L. (1993). Cell Wall Deficient Forms: Stealth Pathogens. Boca Raton: CRC Press. ISBN 9780849387678.
16. Mukamolova G., Turapov O., Young D., Kaprelyants, A. S., Kell, D. B., & Young, M. (2002). A family of autocrine growth factors in M. tuberculosis. Mol. Microbiol., 46 (3), 623–35. doi: 10.1046/j.1365-2958.2002.03184.x.
17. Sanarelli, G., & Alessandrini, A. (1930). Demonstration in vivo et in vitro des forms filtrantes du virus tuberculeux. C. rend. Soc. Biol., 104, 1241.
18. Sheng, T., Kun, C., Tong, H., Guang, L., & Wei, Z. (2009). Study on the relation-ship between Mycobacterium tuberculosis L infection and lung cancer. Tumor, 29, 1085–1089. DOI: 10.3781/j.issn.1000-7431.2009.11.015.
19. Song, L. Y., Yan, W. S. & Zhao, T. (2002). Detection of Mycobacterium tuberculosis in lung cancer tissue by indirect in situ nested PCR. Di Yi Jun Yi Da Xue Xue Bao, 22, 992–993. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12433626.
20. Tian, Y., Hao, T., Cao, B., Zhang, W., Ma, Y., Qiang, Lin, & Xiaomin, Li. (2015). Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host-Pathogen Interaction and Coevolution. BioMed. Research International, 1–9. https://doi.org/10.1155/2015/827829.
21. Tian, Y. S., Cui, X. K., Zhang, W., Ma, Y., Dong, S. F., Zhao, W. Y., & Li, H. G. (2013). Detection of Mycobacterium tuberculosis L-forms and MPB64 gene in breast cancer tissues. Journal of Practical Medicine, 15, 2552–2555. Retrieved from http://en.cnki.com.cn/Article_en/CJFDTOTAL-SYYZ201315053.htm.
22. Zhang, S., Guangling, Z., & Yan-sheng, T. (2009). Detection of Mycobacterium tuber-culosis L forms infection in tissues of lung carcinoma. Chin. J. Public. Health, 25, 1317–1318.
This work is licensed under a Creative Commons Attribution 4.0 International License.